With the introduction of the new annual subscription agreement fee (ASAF) model in the recent investor webinar, I put together some figures for the first major customer, Beth Israel Deaconess Medical Center (BIDMC). This is my interpretation only, please let me know if your figures differ or you identify mistakes.
Some notes:
- Although BIDMC is fully integrated, it is not yet a paying customer due to a contra agreement (use of Echosolv in exchange for services related to the health outcomes study). As a result, I don’t expect any cash flow in the March quarter. The June quarter may see a small amount, but with the 90-day free trials in place, it’s unlikely. The first revenue should appear in the September quarter, either from the misc code or potentially the Cat 3 code if approved. Would be happy to be proven wrong on these points.
- The previously advised split of the reimbursement between EIQ/customer appears to now be void. Use of the software will be free to the customer as reimbursement covers the cost. For the customer to make money on the use of the software the onus is on them to improve the average approval rate of reimbursement thereby generating excess reimbursement revenue above EIQ's ASAF which they will keep.
- I've used the top end of the AS reimbursement being $150 USD though this can vary.
- I've used the total Echos per year performed by BIDMC though this may not be accurate as I'm not certain if they would all relate to AS.
MISC CODE 1 BIDMC Echos per year 30,000.00 2 AS reimbursement $150.00 3 Misc code avg reimbursement approval 30.00% 4 Number of Echos potentially approved for reimbursement 9,000.00 5 EIQ annual subscription agreement fee $1,350,000.00 6 EIQ monthly fee $112,500.00 7 8 CAT 3 CODE 9 BIDMC Echos per year 30,000.00 10 AS reimbursement $150.00 11 Cat 3 code avg reimbursement approval 50.00% 12 Number of Echos potentially approved for reimbursement 15,000.00 13 EIQ annual subscription agreement fee $2,250,000.00 14 EIQ monthly fee $187,500.00 15 16 CAT 1 CODE 17 BIDMC Echos per year 30,000.00 18 AS reimbursement $150.00 19 Cat 1 code avg reimbursement approval 90.00% 20 Number of Echos potentially approved for reimbursement 27,000.00 21 EIQ annual subscription agreement fee $4,050,000.00 22 EIQ monthly fee $337,500.00
- Forums
- ASX - By Stock
- EIQ
- Beth Israel Deaconess - Revenue projection
EIQ
echoiq limited
Add to My Watchlist
0.00%
!
23.0¢

Beth Israel Deaconess - Revenue projection
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $148.3M |
Open | High | Low | Value | Volume |
23.0¢ | 23.5¢ | 23.0¢ | $139.8K | 606.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 772241 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 176250 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 772241 | 0.230 |
9 | 207054 | 0.225 |
26 | 886220 | 0.220 |
7 | 178201 | 0.215 |
7 | 100488 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 176250 | 4 |
0.245 | 307661 | 2 |
0.250 | 152746 | 4 |
0.255 | 442426 | 9 |
0.260 | 170107 | 4 |
Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
Featured News
EIQ (ASX) Chart |